CONA
VNDA icon

Capital One National Association’s Vanda Pharmaceuticals VNDA Stock Holding History

Capital One National Association’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,890
Closed -$338K – 541
2017
Q3 		$338K Sell
18,890
-63
-0.3% -$1.05K 0.02% 422
2017
Q2 		$309K Sell
18,953
-16
-0.1% -$231 0.02% 418
2017
Q1 		$266K Sell
18,969
-102
-0.5% -$1.45K 0.02% 449
2016
Q4 		$304K Sell
19,071
-149
-0.8% -$2.4K 0.02% 419
2016
Q3 		$320K Buy
+19,220
New +$259K 0.03% 417

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital One National Association's VNDA Position: Q4 2017 in Review

Capital One National Association sold out of Vanda Pharmaceuticals (VNDA) in Q4 2017, closing a stake of 18,890 shares — an estimated $338K sold.

Capital One National Association first reported a position in VNDA in Q3 2016 and held it in 5 quarters. The position peaked at $338K in Q3 2017. 125 funds tracked by Wall St. Rank hold VNDA as of Q4 2017.

  • Capital One National Association reported no remaining Vanda Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Capital One National Association sold 18,890 Vanda Pharmaceuticals shares in Q4 2017, an estimated $338K.
  • Capital One National Association first reported a position in Vanda Pharmaceuticals in Q3 2016 and held it in 5 quarters.
  • Capital One National Association's Vanda Pharmaceuticals position peaked at $338K in Q3 2017.
  • 125 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2017.

Based on Capital One National Association's 13F filing for Q4 2017, filed 7 Feb 2018.